Recombinant Proteins

p53
LBP
CEA
HLA
TCL
TTC
NPM
MAF
Bax
BID

F3 Human

Coagulation Factor III Human Recombinant

This product consists of a recombinant human Tissue factor protein. It is a single, non-glycosylated polypeptide chain that includes 219 amino acids from the extracellular domain (amino acids 33-251). It has a molecular weight of 29.39 kDa and includes a 4.5 kDa amino-terminal hexahistidine tag. The protein is produced in E. coli and purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT10603
Source
Escherichia Coli.
Appearance
A clear solution that has undergone sterile filtration.

MCFD2 Human

Multiple Coagulation Factor Deficiency 2 Human Recombinant

Recombinant human MCFD2, expressed in E. coli, is a single, non-glycosylated polypeptide chain consisting of 136 amino acids (residues 27-146). It has a molecular weight of 15.1 kDa. A 16-amino acid T7-Tag is fused to the N-terminus of MCFD2. The protein is purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT11142
Source
Escherichia Coli.
Appearance
A clear, colorless solution that has been sterilized by filtration.

F3 Mouse

Coagulation Factor III Mouse Recombinant

Recombinant Mouse F3 protein, produced in Sf9 insect cells, is a glycosylated polypeptide chain containing 232 amino acids (residues 29-251). It has a molecular weight of 26.4 kDa but migrates at 28-40 kDa on SDS-PAGE due to glycosylation. The protein includes a 6-amino acid His tag at the C-terminus and is purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT10670
Source
Sf9, Baculovirus cells.
Appearance
A clear, colorless solution that has been sterilized by filtration.

F7 Human

Coagulation Factor VIIa Human Recombinant

Recombinant Human Factor VIIa, produced in BHK cells, is a glycosylated polypeptide with two chains forming a dimer. It has a molecular weight of 50kD, consists of 406 amino acids, and is purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT10757
Source
BHK cells (Baby Hamster Kidney Cells).
Appearance
White, lyophilized powder, sterile-filtered.

F8 Human

Coagulation Factor-VIII Human

Human Factor VIII, derived from human plasma, consists of 2332 amino acids and possesses a molecular mass of 330kDa. This factor plays a crucial role in correcting and preventing bleeding episodes associated with Factor VIII deficiency.

Purification of Factor-VIII is achieved through proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT10817
Source

Human Plasma.

Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

F8 Protein

Coagulation Factor-VIII Human Recombinant

Recombinant Human Antihemophilic Factor, produced in CHO cells, is a glycosylated polypeptide chain consisting of 2322 amino acids. Purification of Factor-VIII is achieved using proprietary chromatographic methods.
Shipped with Ice Packs
Cat. No.
BT10905
Source
CHO cells (Chinese Hamster Ovarian Cells).
Appearance
Sterile Filtered White lyophilized powder
Definition and Classification

Coagulation factors are a group of proteins essential for blood clotting, a critical process that prevents excessive bleeding when blood vessels are injured. These factors work in a complex cascade to form a stable blood clot. They are classified into several categories based on their function and structure:

  • Proenzymes (Zymogens): Inactive precursors that are converted into active enzymes. Examples include Factor II (Prothrombin), Factor VII, Factor IX, and Factor X.
  • Cofactors: Non-enzymatic proteins that assist in the activation of proenzymes. Examples include Factor V and Factor VIII.
  • Fibrinogen: A soluble plasma protein that is converted into insoluble fibrin during clot formation.
  • Regulatory Proteins: Proteins that regulate the coagulation process, such as Protein C, Protein S, and Antithrombin.
Biological Properties

Key Biological Properties: Coagulation factors are primarily synthesized in the liver and circulate in the blood in an inactive form. They are activated in response to vascular injury.

Expression Patterns: The expression of coagulation factors is tightly regulated and occurs predominantly in the liver. Some factors, like Factor VIII, are also produced by endothelial cells.

Tissue Distribution: Coagulation factors are found in the plasma, with some factors also present in platelets and endothelial cells.

Biological Functions

Primary Biological Functions: The main function of coagulation factors is to facilitate blood clotting. They achieve this by participating in a cascade of reactions that lead to the formation of a stable fibrin clot.

Role in Immune Responses: Coagulation factors also play a role in the immune response by limiting the spread of pathogens through clot formation and by interacting with immune cells.

Pathogen Recognition: Some coagulation factors can recognize and bind to pathogens, aiding in their clearance from the bloodstream.

Modes of Action

Mechanisms with Other Molecules and Cells: Coagulation factors interact with various molecules and cells, including platelets, endothelial cells, and other plasma proteins. These interactions are crucial for the activation and regulation of the coagulation cascade.

Binding Partners: Key binding partners include calcium ions, phospholipids, and specific receptors on platelets and endothelial cells.

Downstream Signaling Cascades: The activation of coagulation factors triggers a series of downstream signaling events that culminate in the conversion of fibrinogen to fibrin, forming a stable clot.

Regulatory Mechanisms

Regulatory Mechanisms: The expression and activity of coagulation factors are regulated at multiple levels, including transcriptional regulation and post-translational modifications.

Transcriptional Regulation: The synthesis of coagulation factors is controlled by various transcription factors and signaling pathways that respond to physiological and pathological stimuli.

Post-Translational Modifications: Coagulation factors undergo several post-translational modifications, such as glycosylation and gamma-carboxylation, which are essential for their proper function.

Applications

Biomedical Research: Coagulation factors are studied extensively in biomedical research to understand their role in hemostasis and thrombosis.

Diagnostic Tools: Assays that measure the activity of coagulation factors are used to diagnose bleeding disorders and monitor anticoagulant therapy.

Therapeutic Strategies: Coagulation factors are used therapeutically to treat bleeding disorders such as hemophilia. Recombinant coagulation factors and plasma-derived concentrates are commonly used in clinical practice.

Role in the Life Cycle

Development: Coagulation factors are essential for normal development, particularly in the formation of the vascular system.

Aging: The levels and activity of coagulation factors can change with age, contributing to an increased risk of thrombotic events in the elderly.

Disease: Dysregulation of coagulation factors is associated with various diseases, including bleeding disorders, thrombotic disorders, and inflammatory conditions.

© Copyright 2024 Thebiotek. All Rights Reserved.